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Background: Non-infection caused urticaria is a common ailment in adolescents. Its symptoms (e.g., unusual rash
appearance, limitation of daily activities, and recurrent itching) may contribute to the development of depressive
stress in adolescents; the potential link has not been well studied. This study aimed to investigate the risk of major
depression after a first-attack and non-infection caused urticaria.
Methods: This study used the Taiwan Longitudinal Health Insurance Database. A total of 5,755 adolescents hospitalized
for a first-attack and non-infection caused urticaria from 2005 to 2009 were recruited as the study group, together with
17,265 matched non-urticarial enrollees who comprised the control group. Patients who had any history of urticaria or
depression prior to the evaluation period were excluded. Each patient was followed for one year to identify the
occurrence of depression. Cox proportional hazards models were generated to compute the risk of major depression,
adjusting for the subjects’ sociodemographic characteristics. Depression-free survival curves were also analyzed.
Results: Thirty-four (0.6%) adolescents with non-infection caused urticaria and 59 (0.3%) non-urticarial control subjects
suffered a new-onset episode of major depression during the study period. The stratified Cox proportional analysis
showed that the crude hazard ratio (HR) of depression among adolescents with urticaria was 1.73 times (95% CI,
1.13-2.64) than that of the control subjects without urticaria. Moreover, the HR were higher in physical (HR: 3.39, 95% CI
2.77-11.52) and allergy chronic urticaria (HR: 2.43, 95% CI 3.18-9.78).
Conclusion: Individuals who have a non-infection caused urticaria during adolescence are at a higher risk of developing
major depression.
Keywords: Non-infection caused urticaria, Major depression, Adolescent, Pediatric, Hazard ratioBackground
Urticaria is a common disease in children and is esti-
mated to affect 15-25% of people at some point in their
lives [1-3]. Symptoms of urticaria (e.g., recurrent itching,
generalized wheals and sleep disturbances) can persist
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unless otherwise stated.of patient stress [1-8]. There are many etiologies of urti-
caria in children, including foods, infections, physical
contact, temperature changes, and idiopathic causes
[4,9-13]. Moreover, fruits and insect venom have also
been reported to induce allergic reactions or urticaria in
childhood [14,15]. Among children with urticaria, simple
infections have been associated with the majority of
acute episodes [2,9]. However, the stress and urticarial
symptoms caused by simple infections are usually transi-
ent, particularly when patients are protected from the
source of infection.
Non-infection caused urticaria may result in prolonged
or recurrent episodes of urticaria. A first-attack episode
of non-infection caused urticaria can impose limitations. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ample, patients who have suffered from food-induced
urticaria in the past due to peanut allergies would subse-
quently need to eliminate their exposure to peanut-
based products. Thus, an allergy-related event of this
type is stressful to the patient and is also likely to have
an impact on the entire family’s dietary choices. In
addition to the unusual-looking rash, the adolescent’s
interpersonal relationships with peers might result in
limitations of daily activities as the severity of physical
urticaria can be increased by exercise, skin contact and
even sunlight [5,10,16]. One previous study reported that
43% of adult patients with urticarial dermographism ex-
perienced an impact on their quality of life and psycho-
social stress [7]. Other specific dermatologic disorders
have also been reported to be risk factors for the devel-
opment of psychiatric problems in adulthood [6-8,17].
Psoriasis and atopic dermatitis can result in personality
changes or depressive symptoms because of sleep distur-
bances or health-related impairment to quality of life
[6,17]. Similarly, urticaria in adults has been reported to
increase the likelihood of anxiety and depression [8]
However, the relationship between psychiatric problems
and pediatric non-infection caused urticaria is unclear.
To our knowledge, urticaria-related depression in ado-
lescents has never been studied. It is well known that
adolescence is a unique developmental period marked
by processes such as increased cognitive abilities and
physical changes. During this period, adolescents may be
vulnerable to the development of various mental and
physical conditions [18]. Therefore, we suspect that a
first-attack episode of non-infection caused urticaria
might increase the likelihood of suffering a subsequent
episode of new-onset major depression. In this study, we




We used the Longitudinal Health Insurance Database
(LHID) as the data source for this study. The LHID is
derived from medical claims data available to the Bureau
of National Health Insurance and provided to scientists
in Taiwan for research purposes. The government of
Taiwan launched its National Health Insurance (NHI)
program in 1995 to provide affordable health care for all
residents of Taiwan. As of 2007, over 98% of Taiwan's
population was enrolled in this program. The LHID in-
cludes original data from one million people. The data
in this study were randomly sampled from the period
between 2005 and 2009. There were no significant differ-
ences in the gender or age distributions or the average
payroll-related insurance premium rate between the
people in the LHID and all NHI enrollees. The LHIDalso provides a valuable opportunity for researchers to
evaluate medical service use since 1995. The details re-
garding how the database was generated are published on-
line by the Taiwan National Health Research Institutes.
Ethics statement
This study was exempt from a full review by the Institu-
tional Review Board of Changhua Christian Hospital
(permission code: 121007) because the data set consisted
of de-identified secondary data that were released for re-
search purposes without restrictions. In addition, this
manuscript has adhered to the strengthening the report-
ing of observational studies in epidemiology (STROBE)
guidelines.
Study setting and population
This is a retrospective cohort study. During the period
from January 1, 2005, to December 31, 2009, data were
collected from the LHID for two patient groups, the
study group and the control group. The study group was
defined as adolescents who suffered non-infection caused
urticaria. The control group was defined as adolescents
who did not suffer any urticaria. We designated the first
hospitalization for urticaria treatment during this period
as the index hospitalization. In this study, the study group
(with non-infection caused urticaria) and the control
group (without any urticaria) were both followed for one
year. The likelihood of suffering a new-onset episode of
major depression during the one-year follow-up period
was analyzed for the two groups.
Inclusion criteria
Definition of patients with non-infection caused urticaria
Patients who were diagnosed with a principal diagnosis
of urticaria using the International Classification of Dis-
eases, 9th Revision, Clinical Modification codes (ICD-9-
CM; code 708.0 to 708.9) were included in the study
provided they did not have a co-diagnosis of infection
(using ICD-9 codes) [19,20] and did not receive any anti-
biotic agents (including oral, injectable and ear-drop
forms) at the time of their urticarial attack, or for 7 days
before or after their attack. For those non-infection
caused urticaria patients whom continuous treatment re-
cords were available, chronic urticaria was defined as ur-
ticarial symptoms that lasted for more than 6 weeks [1].
The possible etiologies of chronic urticaria were mainly
classified as physical or allergic in nature. In this study,
the chronic urticaria patients were included in the main
study group.
Definition of patients with major depression
Patients were included in the study if they were diag-
nosed by a psychiatrist with major depression as the
principal diagnosis using the ICD-9-CM codes 296.2 and
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definitions and criteria in the Diagnostic and Statistical
Manual of Mental Disorders (DSM) - IV published by
the American Psychiatric Association [21]. Bipolar de-
pression, affective disorder substance-related depression,
postpartum depression and depressive disorder were also
not included as our primary outcomes because the prin-
ciples of their diagnoses and their clinical presentations
are different compared with major depression. Affective
disorder may include manic attacks, and depressive dis-
order has only some of the same symptoms as major
depression.
Exclusion criteria
Patients who had been diagnosed with any form of urti-
caria or depression prior to their index hospitalization
(first-attack of non-infection caused urticaria) were not
included.
Quality control for potential icd-9 over coding and
treatments
To ensure that the medical resources provided by the
government-supported NHI program were not over-
used by the treating hospitals or patients, the diagnosis,
treatments, and medications for each patient were ran-
domly and routinely inspected by specialists. Over-
treatment or over-coding in ICD-9 was not permitted
and can result in fines.
Study protocol
Our study group included 5,755 non-infection caused
urticaria patients (adolescents 13 to 18 years of age).
The control group was selected from the remaining NHI
beneficiaries registered in the LHID. We then randomly
selected 17,265 control patients (three control patients
for each urticaria patient) who were matched to the
study group by gender, age and years of index healthcare
use for further analysis. A total of 23,020 adolescents
were included in this study.
Data analysis
The SAS 9.2 statistical package was used to perform the
study analyses (SAS Institute Inc., Cary, NC, USA). We
used the SAS program to select the study and control
groups. Each patient (n = 23,020) was tracked for one
year after his/her index hospitalization to identify sub-
jects who developed new-onset major depression. The
results of the descriptive analyses of the independent
variables including patient characteristics, demographics,
personal allergy histories, family history (parents/broth-
ers/sisters) of affective disorders are reported as percent-
ages or as the mean ± standard deviation (SD). The X2
test was used to compare the differences between the
study and control groups with regard to demographics,including socioeconomic level (i.e., monthly income of
the patient and guardian > $1000 USD, $601-1000 USD
or < $600 USD), the degree of urbanization in their cities
of residence (levels 1 to 4), the geographical location of
the patient’s residence (northern, central, southern, and
eastern Taiwan), and the personal history of allergic dis-
eases (allergic rhinitis, asthma, and atopic dermatitis).
The degree of urbanization was defined by population
and certain development-related conditions. Level 1
urbanization was defined as a population over 1,250,000
people with specific political, economic, cultural, and
metropolitan development. Level 2 urbanization was de-
fined as a population between 500,000 and 1,250,000
with political, economic and cultural development serv-
ing an important role. Levels 3 and 4 were defined as a
population between 150,000 and 500,000 and less than
150,000 people, respectively.
Furthermore, the crude hazard ratio (HR) was calcu-
lated by creating stratified Cox's proportional hazards
models (stratified by age), which were implemented in
the study and control groups to analyze the risk of ex-
periencing a new-onset of depression. In addition, the
variables that were related and unrelated to the occur-
rence of depression among the urticarial patients were
further analyzed using the X2 test. These variables in-
cluded gender, age, socioeconomic level, the urbanization
level in the city of residence, geographic regions, history
of allergic diseases, family history of affective disorders,
urticaria treatment with corticosteroids (oral and injection
forms) and the mean number of hospital visits (for urti-
caria treatment). Age groups and the causes of chronic ur-
ticaria were also analyzed to identify interactions between
these parameters (case/control groups, demographics and
allergy histories) with a Cox proportional hazards model.
The adjusted HR was analyzed after adjusting for allergic
rhinitis, asthma, atopic dermatitis, family history of
affective disorders, urticaria treatment with corticosteroids
(oral and injection forms), geographic regions, socioeco-
nomic level, and the urbanization level of their cities of
residence. We used the Kaplan-Meier method and the
log-rank test to estimate survival curves and to compare
the one-year depression-free survival rate among urticaria
patients versus patients in the control group. Finally, in
the control group, chronic conditions (e.g., allergic rhin-
itis, asthma, attention deficit disorder, atopic dermatitis,
hypertension, epilepsy, diabetes, congenital heart diseases,
cerebral palsy and cancer) were identified that might in-
crease the risk for affective or anxious disorders [22-31].
Results
Demographics of patients with non-infection caused
urticaria
The characteristics and personal histories of allergic dis-
eases of the study patients (with non-infection caused
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17,265) are presented in Table 1. Among the urticarial
patients, the 16- to 18-year-old age group was the most
represented (54%). Compared with the control patients,
more urticarial patients lived in southern Taiwan. The
urticarial patients also had a significantly higher preva-
lence of allergic diseases than the control group (asthma,
atopic dermatitis and allergic rhinitis, all p < 0.05).
Depression likelihood based on the crude HR
During the one-year follow-up period, the incidence of
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6,093, 35.3%), attention deficit (n = 862, 5.0%), atopic
dermatitis (n = 771, 4.5%), hypertension (n = 401, 2.3%),
epilepsy (n = 345, 2.0%), diabetes (n = 271, 1.6%), congeni-
tal heart diseases (n = 92, 0.4%), cerebral palsy (n = 32,
0.2%) and cancer (n = 16, 0.1%).
Pharmacological treatment (corticosteroids)
There were 2,473 patients who had ever received cortico-
steroids for their urticaria. The prevalence of major depres-
sion was higher in the group treated with corticosteroids
(n = 31, 1.3%) compared with the group without corticoste-
roids (n = 3, 0.1%) (p < 0.05). Moreover, in the adjusted
model, the urticarial patients who had ever received corti-
costeroids were more likely to experience new-onset major
depression compared with the control group patients
(HR = 1.89; 95% CI = 1.23-2.87; p < 0.05) (Table 2).
Characteristics that are associated with the occurrence of
new-onset major depression in patients with non-infection
caused urticaria (n = 5,755)
For the urticarial patients, we found that major depres-
sion was more predominant in the 16- to 18-year-old
age group and history of asthma (both p < 0.05) (Table 3).
Gender and the mean number of hospital visits were not
significantly associated with the onset of depression.





Adolescents with non-infection caused urticaria 1.73 1.13-2.64
Control* 1.00 1.00
Mode 1
Adolescents with non-infection caused urticaria 1.72 1.13-2.63
Control* 1.00 1.00
Mode 2
Adolescents with non-infection caused urticaria 1.71 1.12-2.61
Control* 1.00 1.00
Mode 3
Adolescents with non-infection caused urticaria 1.85 1.17-2.93
Control* 1.00 1.00
Mode 4
Adolescents with non-infection caused urticaria 1.89 1.23-2.87
Control* 1.00 1.00
*Reference group.
Mode 1: Adjusted by demographics (i.e., economic level of family, degree of
urbanization and geographical location).
Mode 2: Adjusted by personal allergy histories (i.e., allergic rhinitis, asthma and
atopic dermatitis).
Mode 3: Adjusted by family history of affective disorders.
Mode 4: Adjusted by treatment (i.e., corticosteroids).histories of allergic diseases, the urticarial patients were
still more likely to experience new-onset major depres-
sion than the control group patients (Table 2). Of all,
there were 217 chronic urticaria patients (physical cause,
n = 82 and allergy cause, n = 135). Three of 82 (3.7%)
physical caused urticaria patients and 2 of 135 (1.5%) al-
lergy caused urticaria patients suffered major depression.
The crude HR of depression of physical causes was 3.39
times (95% CI 2.77-11.52) and of allergy causes was 2.43
(95% CI 3.18-9.78) times greater than that of the control
subjects without urticaria (both p < 0.05). Urticaria-
related depression was significantly more severe than the
depression observed in the control group. Finally, the
age groups and the causes of chronic urticaria did not
exhibit significant interactions with the case/control
groups, demographics or allergy histories.
Depression-free survival curves for patients
The depression-free survival curves for the urticaria and
control patients during the study period are shown in
Figure 1. We noted that the urticaria patients had sig-
nificantly shorter one-year depression-free survival times
than the control patients (all p <0.05).
Discussion
In this one-year follow-up study, we noted that non-
infection caused urticaria significantly caused the subse-
quent major depression. The stratified Cox proportional
analysis showed that the crude hazard ratio of depres-
sion among adolescents with urticaria was 1.73 times
(95% CI, 1.13-2.64) than that of the control subjects with-
out urticaria (p < 0.05). Although the sample size of
chronic urticaria is small, we still noted that physical (crude
HR: 3.39 95%, CI 2.77-11.52) or allergy caused (crude HR:
2.43, 95% CI 3.18-9.78) chronic urticaria have a higher risk
of suffering depression than control group. Some factors
that might potentially influence the occurrence of depres-
sion, including baseline personal allergic histories, eco-
nomic conditions of the family, and geographic regions
were adjusted. Non-infection caused urticaria still signifi-
cantly increased the hazard ratio of major depression. Fi-
nally, the age groups and the causes of chronic urticaria
did not exhibit significant interactions with the case/con-
trol groups, demographics or allergy histories.
The incidence of major depression occurrence of ado-
lescents with non-infection caused urticaria was low
(0.6%); however, it was still significantly higher than ado-
lescents without any urticaria (0.3%). Among these ado-
lescents with non-infection caused urticaria, two patient
characteristics that were most likely to associate a subse-
quent episode of depression. First, the older adolescent
group (aged 16 to 18 years) was more predominant than
the younger adolescents (aged 13 to 15 years). Second, a
history of asthma was the other factor that associates
Table 3 Characteristics associated with the occurrence of new-onset major depression in adolescents with non-infection
caused urticaria
Adolescents with non-infection caused urticaria
(n = 5,755)
Control patients (n = 17,265)
New-onset major depression
occurrence (n = 34) No. (%)
p –value New-onset major depression
occurrence (n = 59) No. (%)
p –value
Gender
Male 15 (44.1) 0.475 22 (37.3) 0.192
Female 19 (55.9) 37 (62.7)
Age group (y/o)*
13-15 8 (23.5) 0.006 19 (32.2) 0.037
16 ~ 18 26 (76.5) 40 (67.8)
Economic level of family (monthly income) (USD$)
<600 15 (44.1) 0.095 21 (35.6) 0.264
601 ~ 1,000 13 (38.2) 26 (44.1)
>1,000 6 (17.6) 12 (20.3)
Urbanization
1 (most) 5 (14.7) 0.251 14 (23.7) 0.123
2 7 (20.6) 3 (5.1)
3 13 (38.2) 25 (42.4)
4 9 (26.5) 17 (28.8)
Geographic regions of Taiwan
Northern 15 (44.1) 0.660 27 (45.8) 0.543
Central 11 (32.4) 12 (20.3)
Southern 7 (20.6) 17 (28.3)
Eastern 1 (2.9) 3 (5.1)
Asthma history* 19 (55.9) 0.020 23 (39.0) 0.589
Atopic dermatitis history 3 (8.8) 0.415 4 (6.8) 0.337
Allergic rhinitis 16 (47.1) 0.425 28 (47.5) 1.000
Family history of affective disorders* 27 (79.4) 0.002 43 (72.9) 0.003
Urticaria treatment with corticosteroids* 31 (91.1) <0.001 -
Mean number of hospital visits (to treat urticaria) 1.6 ± 1.2 0.578 -
*Characteristics associated with depression in study group.
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Table 3 showed that asthma history only significantly as-
sociated with depression occurrence in study group (but
not in control group). Because some children with a his-
tory of asthma have already experienced some limitations
in their daily activities (e.g., avoiding microorganisms from
pets, abstaining from vigorous exercise and avoiding cold
environments and allergenic foods) [32-37], the experi-
ence of new-onset urticaria could further extend these
limitations and increase life stresses. In addition to only
treat the urticarial symptoms, we suspect that the altered
physical appearance (caused by recurrent rashes) and lim-
ited social activities (avoiding exercise and skin contact
that might increase pruritus) might further contribute to
the depressive mood of adolescents. Life stresses, includ-
ing poor quality of life, social phobia, severe itching, andsleep disturbances, are usually present in most adult pa-
tients who have suffered from certain prolonged dermato-
logic diseases [7,8,17]. However, the association between
dermatologic diseases and psychologic problems in ado-
lescents has not been thoroughly addressed. It is well
known that adolescent development represents a time of
increased susceptibility to stress that is marked by in-
creased vulnerability [38]. During adolescence, the brain
demonstrates a high level of plasticity and can be posi-
tively or negatively affected by the environment [18,39].
Because elevated life or social stresses have been demon-
strated to cause depressive episodes in adolescence
[38,40,41]. Therefore, early psychiatric care to prevent de-
pression in adolescents with urticaria may be important.
In addition, affective disorders have been demon-
strated to be increased by chronic autoimmune/allergy
Figure 1 Depression-free survival curves. Depression-free survival curves for the (A) non-infection caused urticaria, (B) physically induced chronic
urticaria and (C) allergy-induced chronic urticaria patients during the 1-year follow-up period (all p < 0.05). The curves for all patients with non-infection
caused urticaria were similar to those in the small cohorts of patients with chronic allergic (n = 135) or physical caused urticaria (n = 82).
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chronic central nerve inflammatory reactions [40-42].
For example, autoimmune diseases (including atopic
dermatitis and systemic lupus erythematosus) and aller-
gic diseases (including allergic rhinitis and asthma) could
increase the risk of depression or bipolar disorders
[28,30,31,43]. Because these autoimmune/allergy dis-
eases are strongly genetic in origin and have been dem-
onstrated to potentially develop as heritable diseases
[44], identifying the family history is important. Identifi-
cation of autoimmune/allergy diseases in parents might
help family physicians in the early detection of children
with silent symptoms. The risks of suffering from
affective disorders might be decreased by the early con-
trol of their chronic autoimmune/allergy conditions.
Limitations
Potential ICD-9 over- or miscoding was an inherent
limitation of this database study. The codes sent to the
National Health Database were only made by attending
physicians in outpatient/emergency departments. Ac-
cording to the Taiwan’s law, all codes must be made and
confirmed by the treating physicians. Because major
depression requires more clearly defined diagnosticcriteria, which we discussed in the methods section, all
cases of major depression were only diagnosed by psy-
chiatrists. Urticaria is a common disease in dermatology,
pediatric and even rheumatology outpatient depart-
ments; therefore, we did not limit the urticaria diagnosis
to diagnoses made by dermatologists. Our procedure for
separating the different divisions of treating physicians
was to trace who required treatment payments from the
government. Excluding patients who had a co-diagnosis
of infection 7 days before or after their urticaria attack
might represent an over exclusion. However, because
upper airway infection and acute gastroenteritis are the
most commonly reported etiologies of infection caused
urticaria [9], we established this exclusion criterion to
account for possible incubation periods. Finally, because
corticosteroids are typically recommended to treat pa-
tients with more itching or recurrent urticaria [45], the
results could have potentially been influenced by the
condition of urticaria.
Conclusion
Individuals who have a non-infection caused urticaria
during adolescence are at a higher risk of developing
major depression than those without urticaria.
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